NIH Guide: Weekly Index for March 20, 2020

Funding Opportunities

• Formative and Pilot Intervention Research for Prevention and Treatment of HIV/AIDS (R34 Clinical Trial Optional)
  (PA-20-141)
  National Institute of Mental Health
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below
• Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)
  (PA-20-142)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of General Medical Sciences
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute of Mental Health
  National Institute of Nursing Research
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): Standard dates apply All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Center of Excellence for Research on Complementary and Integrative Health (P01,Clinical Trial Optional)
  (PAR-20-138)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is May 25, 2020. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)
  (PAR-20-140)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): Standard dates apply.
• Firearm Injury and Mortality Prevention Research (R61 Clinical Trial Optional)
  (PAR-20-143)
  Office of Behavioral and Social Sciences Research
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Center for Complementary and Integrative Health
  Office of Research on Women's Health
  Office of Disease Prevention
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): May 15, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R01 Clinical Trial Optional)
  (RFA-CA-20-027)
  National Cancer Institute
  Application Receipt Date(s): July 31, 2020; July 30, 2021
• Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R21 Clinical Trial Optional)
  (RFA-CA-20-028)
  National Cancer Institute
  Application Receipt Date(s): July 31, 2020; July 30, 2021
• Patient-oriented Research to Mitigate Health Disparities and Lessen the Burden of Chronic Diseases Within the Mission of NIDDK (R01 Clinical Trial Optional)
  (RFA-DK-20-015)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): May 22, 2020 No late applications will be accepted for this Funding Opportunity Announcement.
• Genomic Predictors of Pregnancy Loss (R01 Clinical Trial Not Allowed)
  (RFA-HD-21-005)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  Application Receipt Date(s): July 30, 2020
• Novel Synthetic Nucleic Acid Technology Development (R01 Clinical Trial not allowed)
  (RFA-HG-20-014)
  National Human Genome Research Institute
  Application Receipt Date(s): June 24, 2020; March 9, 2021; February 4, 2022
• Novel Synthetic Nucleic Acid Technology Development (R21 Clinical Trial not allowed)
  (RFA-HG-20-015)
  National Human Genome Research Institute
  Application Receipt Date(s): June 24, 2020; March 9, 2021; February 4, 2022
• Novel Synthetic Nucleic Acid Technology Development (R43/R44)( Clinical Trial not allowed)
  (RFA-HG-20-016)
  National Human Genome Research Institute
  National Center for Advancing Translational Sciences
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): June 24, 2020; March 9, 2021; February 4, 2022 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.